|
Author: trainitright
Rosacea may be a visible warning marker for hidden, potentially serious diseases
VANCOUVER, March 13, 2018 /CNW/ - Canadians who have rosacea should be aware of associations between the disease and increased risk for a variety of disorders - many with potentially serious consequences – in order to detect these diseases at the earliest stage, according to Dr. Jason Rivers, a Vancouver dermatologist and president of the not for profit Acne and Rosacea Society of Canada.

An analysis(1) published early this year showed the highest associations with rosacea were diseases in 4 categories: cardiovascular, gastrointestinal, neurological and autoimmune. Recent studies have shown those with rosacea have higher risks for:
- Cardiovascular disease – 4 times higher
- Gastroesophageal reflux disease (GERD) - 4 times
- Crohn's disease - almost 3 times
- Inflammatory bowel disease (IBD) - 2 times
- Celiac disease - 2 times
- Type 2 diabetes - 2.5 times
People with rosacea also have a 10 times higher risk of food allergies, 7.5 times greater risk of urogenital diseases (affecting the urinary tract or reproductive organs) and 4 times elevated risk for respiratory diseases.
"These studies show association but do not demonstrate cause," says Dr. Rivers. "For example, rosacea is not caused by these conditions nor do these conditions cause rosacea. These studies show that these disorders tend to co-exist together where if you have one, you have a higher chance of having the other."
The role of inflammation – the immune system's response to potential threat or harm - appears to be a common thread. Rosacea, affecting 3 million Canadians, is an inflammatory skin condition characterized by facial redness, pimples and sometimes irritated eyes. Inflammation is thought to play a role in these cardiovascular, gastrointestinal, neurological and autoimmune diseases.
"Inflammation present in these other conditions is hidden within the body," Dr. Rivers added. "However, rosacea appears on the skin making it a visible marker of inflammation that may be helpful as a warning sentinel for these other conditions."
An important consideration for those with rosacea is that being at risk for these conditions does not mean he or she will go on to develop any of these disorders. "Disease development is different for everyone. Family history, personal history, age, gender, environment, lifestyle and other factors all play a role in disease development," he adds.
"However, simply being aware of the associations of rosacea and elevated risk for these potentially serious conditions can help with early detection, diagnosis and treatment," said Dr. Rivers.
Reference:
- Rosacea comorbidities and future research: The 2017 update by the National Rosacea Society Expert Committee. Gallo RL, Granstein RD, Kang S, Mannis M, Steinhoff M, Tan J, Thiboutot D.J Am Acad Dermatol. 2018 Jan;78(1):167-170. doi: 10.1016/j.jaad.2017.06.150
About the Acne and Rosacea Society of Canada:
The society, a national, not for profit organization, offers hope and help to sufferers by providing independent, reputable and current information on rosacea and raising awareness. For more, visit www.RosaceaHelp.ca
About Rosacea Awareness Month
Rosacea Awareness Month, April 2018, was designated by the Acne and Rosacea Society of Canada (www.RosaceaHelp.ca) to raise awareness about rosacea, a common skin condition affecting more than 3 million Canadians that can cause significant physical and emotional effects.
Media resources:
- Dermatologists with the society are available for media interviews
- 2018 Rosacea Facts and Stats Sheet
- Images of rosacea
During April, the society will be posting news to our bilingual website, www.RosaceaHelp.ca, and Facebook Page, Rosacea Help, and @RosaceaHelp on Twitter.
For more information or to organize an interview with spokespeople for Acne and Rosacea Society of Canada:
Dr. Jason Rivers, Vancouver; Dr. Benjamin Barankin, Toronto; Dr. Jerry Tan, Windsor; Dr. Ari Demirjian and Dr. Jean-Francois Tremblay, Montreal; Dr. Marni Wiseman, Winnipeg; Dr. Catherine Zip, Calgary, Dr. Shannon Humphrey and Dr. Marcie Ulmer, Vancouver

SOURCE Acne and Rosacea Society of Canada

- Soft, flexible brush head reaches all corners of the mouth
- Quick-drying, non-porous and 100% waterproof
- Resists the buildup of bacteria for up to 10,000x less bacteria than nylon-bristled toothbrushes
- Soft silicone bristles are gentle on gums and won’t scratch tooth enamel
- 16 variable speeds, as well as a built-in timer to prevent over-brushing.
- Rechargeable via USB, lasts up to 365 uses.
- Ideal for traveling: travel lock feature and no bulky charging dock to transport.
- Savvy oral health investment: ISSA 2’s hybrid brush head lasts for 6 months before needing to be replaced, while the sensitive 100% silicone one lasts for the whole year
- Two-year limited warranty and a 10-year quality guarantee.
When it comes to the great ideas – many were devised while the innovator was sleeping – or in a dream.
In fact, Einstein’s theory of relativity has been voted the greatest idea ever inspired during sleep.
That's according to a new international poll researched by Calm, the popular meditation and sleep app.
The full list and additional info and explanations are below – including tips/hacks on how people can learn to “sleep-storm” or brainstorm while sleeping to be more creative.
-------
Q. The following ideas were all conceived during sleep and/or inspired by dreams.
Which ONE of these ideas would you consider the best or “greatest” idea?
Rank Idea % of respondents
1 - The theory of relativity, by Einstein - 23%
2 - The periodic table of chemical elements - 13%
3 - The invention of the sewing machine - 10%
4 - The model of the atom, conceived by physicist Neils Bohr - 7%
5 - “Yesterday”, the Beatles song by Paul McCartney - 5%
6 - “Terminator”, the movie(s) and movie character - 3%
6 - The principles of analytical geometry, devised by René Descartes - 3%
8 - “Frankenstein”, the novel by Mary Shelley - 2%
8 - “I Can’t Get No Satisfaction”, the Rolling Stones song by Keith Richards - 2%
10 - “The Strange Case of Dr. Jekyll and Mr. Hyde”, the novella by Robert Louis Stevenson - 1%
10 - “Kubla Kahn”, the poem by Samuel Taylor Coleridge - 1%
10 - The discovery of the structure of the benzene molecule - 1%
None of these - 15%
Don’t know - 16%
-----
The poll was commissioned by the app Calm, recently named Apple’s App of the Year.
Calm helps users relax and sleep with a growing library of sleep music and 80+ bedtime stories for grown-ups known as Sleep Stories.
“It’s a stunning list,” says Alex Tew, co-founder of Calm.
“Sleep is not just vital to health but perhaps the greatest single source of creativity.”
Some items to note:
Einstein’s famous theory comfortably topped the poll with 23% of the vote ahead of the periodic table on 13% and the sewing machine on 10%.
No other idea, including “Yesterday” (5%), polled more than single figures.
Einstein’s journey to the theory of relativity reportedly began with a dream about a field of cows surrounded by an electric fence. But when he told the farmer who he met in the dream what he’d seen and the farmer’s account differed, it gave Einstein the key insight that the same event could look different from different perspectives.
The periodic table of chemical elements seems to have appeared fully formed to the Russian chemist Dmitri Mendeleev in his sleep on the night of February 17, 1869. “I saw in a dream a table where all the elements fell into place as required,” he wrote. “Awakening, I immediately wrote it down on a piece of paper. Only in one place did a correction later seem necessary.”
“Yesterday”, The Beatles song whose tune came to Paul McCartney in his sleep one night in 1964, polled highest of any idea from the arts rather than sciences, ranking fifth overall – one behind the model of atom, devised by the Danish physicist Neils Bohr.
Sixth place in Calm’s poll went jointly to Terminator, the movie character which first appeared to director James Cameron in a dream, and the principles of analytic geometry devised by René Descartes, the 17th century French philosopher and mathematician who reputedly slept up to 12 hours a day.
Keith Richards of The Rolling Stones did not even have to write down the opening verse of the great Stones’ song, “I Can’t Get No Satisfaction”. When he woke in the morning of May 7, 1965, he found that he had unwittingly committed it to a tape recorder during the night.
-----
Life-Hacks: Four Ways To Come Up With Ideas In Your Sleep
Is “Sleep-storming” the new brainstorming?
Not only is it possible to boost your odds of generating ideas while you sleep but there’s even a scientific name for it:
“Structured unconscious generative ideation”.
A non-scientific name for it might be “sleep-storming” – as in brainstorming, done solo while you’re asleep.
But can you really train your brain to harvest your sleep for ideas? And is sleep-storming the new brainstorming?
Here are four simple ways suggested by Calm to increase your chances of coming up with ideas while you sleep – and/or capturing the ones that you do.
1 - Keep a Notebook Handy + Write Down Your Dreams
It can be hard to remember your dreams and/or any ideas they inspire. So, always keep a notebook by your bed. Get into the habit of writing down your dreams – and any ideas they might trigger – immediately on waking and almost before you are fully awake. Write down every dream you can recall rather than being selective. The act of writing them down helps you build a relationship with your subconscious, which should in turn help improve your dream recall.
“I always keep a notebook by my bed,” says Michael Acton-Smith, co-founder of Calm. “I often wake up in the night to jot down ideas – and then do so again first thing in the morning.”
2 - Ask Your Subconscious The Question You’re Trying to Answer
“Never go to sleep without a request to your subconscious”, advised Thomas Edison, the great inventor. So, instead of just falling asleep, brief or prime your subconscious to generate new ideas. Before falling asleep, ask yourself the question that you’re trying to answer; then, finally, focus on something else, such as reading or relaxation techniques.
3 - Wake Yourself Mid-Sleep
Waking yourself while dreaming or starting to fall asleep was a technique used by both the artist Salvador Dalí and the inventor Thomas Edison. Dali would put a tin plate on the floor and then sit on a chair beside it, holding a spoon over the plate. He’d then try to doze off so that the spoon would fall and wake him. Edison did similar but with ball bearings and a saucepan. The aim for both was to jolt themselves awake in order to capture ideas from their dreams.
4 - Learn to Have “Lucid Dreams”
Lucid dreaming is the sense of being consciously aware that you are dreaming. This state can help you to explore ideas, control elements of your dream and have better than normal dream recall than. Learning to dream lucidly takes time and practice. You need to try repeating a mantra telling yourself that you want to dream or know that you are dreaming and, for example, want to be aware that you are dreaming and to remember the dream.
|
Government of Canada supporting innovative health research at the University of Regina
Researchers receive funding for cutting-edge research projects to study addiction and the health of personal support workers
REGINA, March 12, 2018 /CNW/ - Scientific discovery holds the key to finding solutions to many of the economic, social, and health challenges we face as a nation and around the world. That is why the Government of Canada proudly supports science in a number of key areas, which is ensuring Canadians thrive in the years to come.
Today, while visiting the University of Regina, the Honourable Ralph Goodale, Minister of Public Safety and Emergency Preparedness, highlighted a recent federal investment of $937,000 for health research at the University of Regina. This support, through the Canadian Institutes of Health Research (CIHR), is part of a larger investment of $372M to enable researchers to study a full spectrum of health issues affecting the lives of Canadians.
While visiting the university, Minister Goodale met with Dr. Randy Johner, who received $451,000 to explore the use of smartphones and tablets to deliver culturally adapted substance addiction treatment support for people in remote and rural areas. Research has shown that the use of technology devices for delivering substance addiction treatment is not only cost-efficient when compared to treatment delivered by a counselor, but that it is also effective at engaging and treating patients with substance addiction issues.
The Minister also took a moment to recognize the work of the University of Regina's Dr. Shanthi Johnson. Dr. Johnson's team received a CIHR grant of $485,000 to enroll older adults receiving home care and their personal support workers in a home support exercise program. The goal of Dr. Johnson's project is to improve the physical health and reduce the incidence of falls among older adults while lowering rates of musculoskeletal disorders among personal support workers, whose jobs often result in strains and injuries from repeated lifting and carrying.
Quotes
"Congratulations to the researchers who have received these CIHR grants. Your important work holds the key to saving lives, discovering new treatments, scientific breakthroughs, the creation of the new knowledge that is at the core of advances in health, as well as achieving long-term cost savings in the health care system."
The Honourale Ralph Goodale
Minister Public Safety and Emergency Preparedness
"This $372 million represents an enormous investment in health research for the science community and benefits all of Canada. Through these grants, CIHR is supporting researchers at all career stages, across the entire country, and in all areas of health research. Our investigators have made Canada a global leader in health research."
Dr. Roderick R. McInnes, CM, O.Ont, MD, PhD, FRSC
Acting President, Canadian Institutes of Health Research
"University of Regina researchers are dedicated to improving the health of Canadians. Whether through developing technology that is able to provide culturally centred substance addiction support or by implementing exercises designed to improve health, reduce falls and lower rates of musculoskeletal disorders in older adults and their continuing care aides, these made-in-Saskatchewan innovations are truly changing lives for the better."
Dr. Vianne Timmons
President and Vice-Chancellor, University of Regina
"I am very excited to receive this CIHR award. For the next three years, our multidisciplinary team of researchers from social work, engineering, sociology, medicine and nursing, will develop and pilot substance use treatment interventions for individuals with diverse learning needs, while using innovative technologies to develop a culturally-informed application (App). This project will build university and community partnerships, with the direct involvement of the Métis Addictions Council of Saskatchewan Inc. and their community members who will assist with creating and testing the App.
Dr. Randy Johner
Associate Professor of Social Work, University of Regina
At the Canadian Institutes of Health Research (CIHR) we know that research has the power to change lives. As Canada's health research investment agency, we collaborate with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system.
SOURCE Canadian Institutes of Health Research
Praluent® (alirocumab) significantly reduced risk of cardiovascular events in high-risk patients, and was associated with lower death rate
- ODYSSEY OUTCOMES trial met its primary endpoint, demonstrating that high-risk patients who added Praluent® (alirocumab) to maximally-tolerated statins experienced significantly fewer major adverse cardiovascular events compared to those on maximally-tolerated statins alone
- For the first time, adding a lipid-lowering therapy to maximally-tolerated statins was associated with reduced death from any cause
- More pronounced effect observed in patients with baseline LDL-C levels at or above despite maximally-tolerated statins, who are at high risk of suffering a future event; in this group, Praluent reduced risk of major adverse cardiovascular events by 24% and was associated with a 29% lower risk of death overall
- In this 18,924-patient, long-term trial, the safety profile of Praluent was consistent with previous trials and no new safety issues were observed
LAVAL, QC, March 10, 2018 /CNW Telbec/ - Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the ODYSSEY OUTCOMES trial met its primary endpoint, showing Praluent® (alirocumab) significantly reduced the risk of major adverse cardiovascular events (MACE) in patients who had suffered a recent acute coronary syndrome (ACS) event such as a heart attack. Results from the trial was presented today during a late-breaker session at the American College of Cardiology's 67th Annual Scientific Session (ACC.18) in Orlando, Florida and are available here.

Key findings include:
- On the primary endpoint, Praluent reduced the overall risk of MACE by 15% (HR=0.85, CI: 0.78-0.93, p=0.0003). The MACE composite endpoint includes patients who experienced a heart attack, ischemic stroke, death from coronary heart disease (CHD), or unstable angina requiring hospitalization.
- Praluent was also associated with a lower risk of death overall, known as "all-cause mortality" (HR=0.85; CI: 0.73-0.98, nominal p=0.026), and there were also numerically fewer CHD deaths (HR=0.92; CI: 0.76-1.11, p=0.38).
- In a pre-specified analysis, the patients with baseline LDL-C levels at or above 100 mg/dL (2.6 mmol/L) experienced a more pronounced effect from Praluent, reducing their risk of MACE by 24% (HR=0.76, CI: 0.65-0.87). In a post-hoc analysis of this group, Praluent was associated with a lower risk of death from any cause by 29% (HR=0.71, CI: 0.56-0.90).
- The analyses described above include the results from 730 patients (8%) in the Praluent group who continued to be assessed in the Praluent arm despite stopping active Praluent therapy, as specified in the protocol for patients with persistent LDL-C readings below 15 mg/dL.
- For those in the Praluent treatment arm, approximately 75% of patient time was on the 75 mg dose.
- There were no new safety signals in the trial, with injection site reactions experienced more commonly in the Praluent group compared to patients on maximally-tolerated statins alone (3.8% Praluent; 2.1% placebo). There was no difference in neurocognitive events (1.5% Praluent; 1.8% placebo) or new-onset diabetes (9.6% Praluent; 10.1% placebo).
"This trial was consistent with earlier statin trials, showing the greatest benefit in patients with higher cholesterol levels at baseline," said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer, Regeneron. "Many patients who have survived a recent heart attack or other coronary event are unable to reach an LDL cholesterol goal of less than 100 mg/dL, and have an urgent need for new therapeutic options because of their increased risk of another event. In this trial, such patients who received Praluent on top of maximally-tolerated statins had important reductions in their risk."
"Not all patients with heart disease are the same. Through this trial, we have been able to identify high-risk patients treated with optimal statins who still have an urgent need for additional treatment options," said Elias Zerhouni, M.D., President, Global R&D, Sanofi. "With nearly 90 percent of the patients in this trial on high-intensity statins, the data demonstrate that a precision-medicine approach in the field of cardiovascular disease may further advance how we better treat high-risk patients."
"The results of this study, the only one specifically designed to evaluate the long-term clinical benefit of Praluent initiation with patients post acute coronary syndrome, demonstrate the value that Praluent can bring to the health of those who are unable to reach their LDL-C health goals," claimed Niven Al-Khoury, President, Sanofi Canada. "With over 60 years of experience working to understand and support the healthcare needs of patients, bringing valuable solutions is core to our purpose."
About ODYSSEY OUTCOMES
ODYSSEY OUTCOMES (n=18,924) assessed the effect of Praluent on the occurrence of MACE in patients who had experienced an ACS between 1-12 months (median 2.6 months) before enrolling in the trial, and who were already on maximally-tolerated statins. All patients were randomized to receive Praluent (n=9,462) or a placebo (n=9,462) and were treated for an average (median) of 2.8 years, with some patients being treated for up to five years. Approximately 90% of patients were on a high-intensity statin.
The trial was designed to maintain patients' LDL-C levels between 25-50 mg/dL (0.6 -1.3 mmol/L), using two different doses of Praluent (75 mg and 150 mg). Praluent-treated patients started the trial on 75 mg every 2 weeks, and switched to 150 mg every 2 weeks if their LDL-C levels remained above 50 mg/dL (1.3 mmol/L) (n=2,615). Some patients who switched to 150 mg switched back to 75 mg if their LDL-C fell below 25 mg/dL (0.6 mmol/L) (n=805), and patients who experienced two consecutive LDL-C measurements below 15 mg/dL (0.4 mmol/L) while on the 75 mg dose (n=730) stopped active Praluent therapy for the remainder of the trial.
About Praluent
Praluent inhibits the binding of PCSK9 (proprotein convertase subtilisin/kexin type 9) to the LDL receptor and thereby increases the number of available LDL receptors on the surface of liver cells, which lowers LDL-C levels in the blood. The use of Praluent to reduce the risk of MACE is investigational and has not been evaluated by any regulatory agency.
Praluent is approved in more than 60 countries worldwide, including the U.S., Japan, Canada, Switzerland, Mexico and Brazil, as well as the European Union (EU).
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
The effect of Praluent on cardiovascular morbidity and mortality has not been determined.
For the product monograph: http://products.sanofi.ca/en/praluent.pdf
About Regeneron Pharmaceuticals, Inc
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led by physician-scientists for 30 years, our unique ability to repeatedly and consistently translate science into medicine has led to six FDA-approved treatments and over a dozen product candidates, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, heart disease, allergic and inflammatory diseases, pain, cancer, infectious diseases and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through its proprietary VelociSuite® technologies, including VelocImmune® to yield optimized fully-human antibodies, and ambitious initiatives such as the Regeneron Genetics Center, one of the largest genetics sequencing efforts in the world.
For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
About Sanofi
Sanofi (EURONEXT: SAN) (NYSE: SNY) is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
Sanofi entities in Canada employ close to 1,900 people. In 2016 we invested $130 million in R&D in Canada, creating jobs, business and opportunity throughout the country.
Follow us on Twitter @SanofiCanada and on YouTube.
Sanofi, Empowering Life
SOURCE SANOFI
86 Unbelievable Facts About Running (Infographic)
Each day, millions of people from all around the world go for a run. Some run marathons, some go out for a jogging session, and some venture into the mountains for an uphill sprint. However, all of these runners have one thing in common; they are all healthy.
It’s no secret that running is one of the healthiest activities that you can take on. From the numerous cardiovascular benefits to the powerful calorie-burning properties, regular running will help you keep your body healthy and in shape for many years to come. Moreover, running is an activity for people of all ages. The youngest marathon finisher was only five years old at the time of the race, and the oldest one was 101.
However, like every other dynamic activity, running requires preparation, adequate equipment, and caution. While running itself has no downsides, running-related injuries are more common than you may think. In fact, 65% of all runners suffer an injury within their first year of running.
So, as quality equipment is key, make sure you buy a pair of legitimate running shoes – Nike is an outstanding brand offering just that! Warm up properly, play some music over your headphones, and you are ready for a run. But before you do all that, make sure you read the other running facts in the infographic below; you will be motivated even more.

Losing weight and staying fit and healthy are consistently among the top 10 New Year’s resolutions, but 80 percent of people fail to keep their resolutions longer than six weeks. March is about the time that most resolutions will be abandoned - mainly because they haven’t produced any immediate results. Dianna Forsberg (http://diannaforsberg.com), international fitness model and health and wellness coach, outlines the best ways to stay on track to reach your fitness goals in the New Year.
1. Reality check. Recognize the stressors in your life. Don’t ignore them. When we ignore them, we continue to use those “coping mechanisms”, which is usually consuming junk food, unhealthy beverages and we hardly make time to workout because we are lacking energy.
2. Write out your desired goals. It can be as small as incorporating more fruits and vegetables. Working out 30 min a day, 3 times a week. Lose 5-10 lbs with 4-6 weeks. Whatever YOUR goal is, write it down.
3. Find a support system. Everyone wants to feel better and do better. The average person is happy to lose 5-10 lbs and maintain it. Talk to your close friends about your goals. Make a Facebook post and see who wants to join you. We are more likely to commit when we have an accountability partner.
4. Invest in a trainer, consultant or health and wellness coach to help you succeed. Seeking professional help from a third party usually works best. In most cases, we tend to take advice and guidance better from a professional.
5. Meal prep once or twice a week to save time. Plan your workouts. Figure out if you will workout before or after work. Stick to the plan. Once you remove the junk from your regime, just say NO! Reach for healthy snacks like unsalted almonds, banana, a green apple, cucumber slices, hard boiled eggs, fresh berries, etc.
6. Now that you have recognized what wasn’t working just a few short weeks ago. Now it’s time to truly commit, be consistent and get it done!
![]() |
![]()
March 7, 2018 (Waterloo, ON) - Local not-for-profit STEM Camp looks to Dragons’ Den for help to solve Canadian Girls in STEM issue
For a full Media Kit with pictures goes to Newsroom.
Content:
It is well known that Canada does not come close to gender parity in STEM-related fields.1 Why is this? And, why is this an issue? According to STEM Camp CEO, Kevin Cougler, the answer to the first question is a challenge but the answer to the second question is simply that it’s a numbers game.
“If we look at gender parity as a purely mathematical concept, we would begin by agreeing that, if we aren’t attracting enough girls to STEM careers it is a potentially untapped market”, indicates Cougler. “Why wouldn’t we want the best and brightest minds in our STEM fields? The more girls we can inspire to consider these careers the better chance we have of finding the best people.”
Cougler feels the Dragons could help. “Not attracting girls to STEM careers is a generational and national challenge. The Dragons’ Den is a national program that could bring much needed attention to this issue. With the help of the Dragons we may be able to inspire parents to talk about the career opportunities available for their girls and the importance that STEM education will play in a future where 80-90% of jobs will require STEM skills” stated Cougler. “That’s what today was all about in our quest to be chosen for CBC’s Dragons’ Den.”
STEM Camp is a Canadian not -for-profit summer camp that was started by Cougler in 2013 with a mission to inspire and prepare today’s youth for a future of STEM careers. At the camp, youth participate in Science, Technology, Engineering and Mathematics (STEM) activities that are designed to be fun and engaging. Since 2013, STEM Camp has grown from 2 locations and 80 campers to 77 locations and an estimated 15,000 campers during the summer of 2018. Cougler was joined today by his father Ron, Executive Director, and their new friends Blaine and Rosie who participated in a contest where they had to convince their parents that they should be the first girl to go to the moon. They convinced their parents but also STEM Camp!
It is of interest to note that STEM Camp’s enrolments of girls has seen a steady increase each year, bringing girls one step closer to gender parity. While Cougler still doesn’t know the answer to question one (1) above, he is encouraged by the small contribution his summer STEM Camp is making to the problem. Learn more from STEM Camp’s website2, Facebook. Instagram and Twitter.
Resources
1 http://www.statcan.gc.ca/pub/75-006-x/2013001/article/11874-eng.pdf
2 Website: stemcamp.ca
STEM Camp Contact Information
Larissa Mendonca, Marketing and Communications Coordinator
STEM Camp
t: 519-475-6600 x11

